Rasmussen syndrome in a tropical environment: a study of six (6) observations.

Autor: Guelngar, Carlos Othon, Mohamed Lamine, Touré, Mamadou Ciré, Barry, Mamady, Diakité, Mahadi, Konaté, Bachir Abdoul, Djibo Hamani, Foksouna, Sakadi, Fatimata, Djibo Hassane, Naby, Camara, Dago François, Kassa, Fatimatou Korka, Bah, Doussou, Camara, Victorine, Millimono, Salematou, Condé, Aminata, Sakho, Mohamed Tafsir, Diallo, Souleymane Djigué, Barry, Mamadou Saliou, Diallo, Fodé Mohamed, Soumah, Aminou, Sanni Yaya
Předmět:
Zdroj: Egyptian Journal of Neurology, Psychiatry & Neurosurgery; 11/24/2021, Vol. 57 Issue 1, p1-8, 8p
Abstrakt: Background: In sub-Saharan Africa, encephalitis of various etiologies is a major public health problem and Rasmussen syndrome is rarely diagnosed due to under-medicalization. The objective of this study is to describe the clinical and neuroradiological forms, especially since this affection is little known in sub-Saharan Africa as evidenced by the scarcity of publications. Results: A retrospective, descriptive and analytical study of six (6) cases of Rasmussen syndrome, shows that it is an unrecognized disease in Africa. Men were more represented with a frequency of 67% with a young age. The clinical picture dominated by 100% seizures, mental deterioration and hemiparesis. The etiology is still questionable, probably autoimmune in our study. Conclusion: Rasmussen syndrome accounts for 3% in 219 patients hospitalized for epileptic conditions. This study shows a clinical profile dominated by recurrent epileptic seizures refractory to the drugs Phenobarbital, Valproic Acid and Carbamazepine, the only antiepileptics available in the country. These results are valid for therapeutic and prognostic discussion. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index